| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |